Enact Announces New $500 Million Share Repurchase Program And $0.21 Per Share Quarterly Dividend
Additionally, Enact's Board of Directors declared a quarterly dividend of $0.21 per common share, payable on March 19, 2026, to shareholders of record on February 26, 2026.
“The Board's authorization of a new $500 million share repurchase program reflects the strength of our balance sheet and our continued confidence in Enact's long-term performance,” said Rohit Gupta, Enact's President and Chief Executive Officer.“The authorization reinforces our disciplined approach to capital management and our commitment to returning excess capital to shareholders while maintaining the financial flexibility to support our customers and invest in our business.”
Enact's new share repurchase program authorizes the purchase of up to $500 million of the company's common stock utilizing a variety of methods, including open market purchases, and privately negotiated transactions, and may be made under Rule 10b5-1 and Rule 10b-18 trading plans, at such times and in such amounts as management deems appropriate. In support, Enact has entered into an agreement with Genworth Holdings, Inc. to repurchase its Enact shares as part of the program to maintain Genworth's current ownership interest in Enact.
Enact expects the timing and amount of any share repurchases will be opportunistic and will depend on a variety of factors, including Enact's share price, capital availability, business and market conditions, regulatory requirements, and debt covenant restrictions. The program does not obligate Enact to acquire any amount of common stock, it may be suspended or terminated at any time at the Company's discretion without prior notice, and it does not have a specified expiration date.
About Enact Holdings, Inc.
Enact
This press release was published by a CLEAR® Verified individual.
CONTACT: Investor Contact Daniel Kohl... Media Contact Sarah Wentz...
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment